Applied Therapeutics (APLT) Competitors $0.52 +0.04 (+8.87%) As of 11:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. ANNX, MNPR, AVTE, KOD, INZY, AARD, UPXI, ACB, SCPH, and ZYBTShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Annexon (ANNX), Monopar Therapeutics (MNPR), Aerovate Therapeutics (AVTE), Kodiak Sciences (KOD), Inozyme Pharma (INZY), Aardvark Therapeutics (AARD), Upexi (UPXI), Aurora Cannabis (ACB), scPharmaceuticals (SCPH), and Zhengye Biotechnology (ZYBT). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. Its Competitors Annexon Monopar Therapeutics Aerovate Therapeutics Kodiak Sciences Inozyme Pharma Aardvark Therapeutics Upexi Aurora Cannabis scPharmaceuticals Zhengye Biotechnology Annexon (NASDAQ:ANNX) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Does the media prefer ANNX or APLT? In the previous week, Annexon had 6 more articles in the media than Applied Therapeutics. MarketBeat recorded 6 mentions for Annexon and 0 mentions for Applied Therapeutics. Applied Therapeutics' average media sentiment score of 0.00 beat Annexon's score of -1.00 indicating that Applied Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Annexon Negative Applied Therapeutics Neutral Do analysts recommend ANNX or APLT? Annexon currently has a consensus price target of $12.50, indicating a potential upside of 417.60%. Applied Therapeutics has a consensus price target of $6.10, indicating a potential upside of 1,079.88%. Given Applied Therapeutics' higher probable upside, analysts clearly believe Applied Therapeutics is more favorable than Annexon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Annexon 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is ANNX or APLT more profitable? Annexon's return on equity of -54.45% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AnnexonN/A -54.45% -46.56% Applied Therapeutics N/A -184.67%-84.02% Which has more volatility & risk, ANNX or APLT? Annexon has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.82, indicating that its stock price is 82% more volatile than the S&P 500. Which has better earnings & valuation, ANNX or APLT? Applied Therapeutics has higher revenue and earnings than Annexon. Annexon is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnnexonN/AN/A-$138.20M-$1.18-2.05Applied Therapeutics$460K159.12-$105.62M-$0.43-1.20 Do insiders & institutionals believe in ANNX or APLT? 98.3% of Applied Therapeutics shares are owned by institutional investors. 12.7% of Annexon shares are owned by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryApplied Therapeutics beats Annexon on 8 of the 13 factors compared between the two stocks. Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$73.06M$3.03B$5.63B$9.41BDividend YieldN/A2.49%4.01%4.02%P/E Ratio-1.2021.0528.4320.05Price / Sales159.12273.66415.6587.96Price / CashN/A41.6635.9658.29Price / Book1.068.138.525.82Net Income-$105.62M-$55.10M$3.24B$258.18M7 Day Performance18.12%7.09%4.58%3.68%1 Month Performance72.33%21.12%12.60%14.51%1 Year Performance-90.34%5.91%35.87%19.00% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics4.1702 of 5 stars$0.52+8.9%$6.10+1,079.9%-90.7%$73.06M$460K-1.2030ANNXAnnexon2.3252 of 5 stars$2.39-0.6%$12.50+424.1%-59.3%$261.66MN/A-2.0260Negative NewsMNPRMonopar Therapeutics2.4309 of 5 stars$43.08+4.9%$60.00+39.3%+1,324.3%$261.36MN/A-12.2710AVTEAerovate TherapeuticsN/A$9.00-8.4%N/A-86.5%$260.87MN/A-3.0120High Trading VolumeKODKodiak Sciences3.6293 of 5 stars$4.99+5.3%$9.00+80.4%+86.6%$260.63MN/A-1.3690Gap UpINZYInozyme Pharma2.8731 of 5 stars$4.00flat$11.75+193.8%N/A$258.25MN/A-2.3750Positive NewsAARDAardvark TherapeuticsN/A$11.75+1.3%$33.00+180.9%N/A$254.93MN/A0.0018Gap UpUPXIUpexi1.8184 of 5 stars$6.82-6.1%$16.00+134.6%-8.1%$254.64M$16.56M0.00130Gap DownHigh Trading VolumeACBAurora Cannabis0.2689 of 5 stars$4.51+0.6%N/A-19.2%$253.79M$246.72M41.051,130SCPHscPharmaceuticals4.4006 of 5 stars$4.80+5.8%$14.00+192.0%+15.2%$252.86M$36.33M-2.5130News CoveragePositive NewsZYBTZhengye BiotechnologyN/A$5.35-1.1%N/AN/A$252.36M$25.53M0.00278Gap Up Related Companies and Tools Related Companies Annexon Alternatives Monopar Therapeutics Alternatives Aerovate Therapeutics Alternatives Kodiak Sciences Alternatives Inozyme Pharma Alternatives Aardvark Therapeutics Alternatives Upexi Alternatives Aurora Cannabis Alternatives scPharmaceuticals Alternatives Zhengye Biotechnology Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLT Stock Alerts